FDA Funding Level Creates Problems Beyond Staff Shortages – OND Head
This article was originally published in The Tan Sheet
Executive Summary
FDA's funding level not only limits its staffing resources, but also prevents it from starting necessary information technology upgrades and from supporting research crucial to improving the efficacy and safety of OTC and other drugs, says Office of New Drugs Direct John Jenkins, MD